DJIA 15,307.17 -80.41 -0.52%
NASDAQ 3,463.30 -38.82 -1.11%
S&P 500 1,655.35 -13.81 -0.83%

Merck & Co., Inc.

NYSE: MRK


company name or ticker
Company Photos
(Click to zoom)

Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulin

1 Great Dividend You Can Buy Right Now

This stocks yield may not be a jaw-dropper yet, but it's positioned "purrrrrfectly" in a rapidly growing sector to deliver long term profits and payouts.

The 3 Deadliest Diseases in the U.S.

These deadly diseases kill more than 1 million Americans every year. But there's still some good news.

Statin Users May Have a Reason to Rejoice After This Data

An American Society of Clinical Oncology abstract demonstrates a potentially positive long-term side effect of statin use.

AbbVie Investors, Watch This Management Change

What strategy will the company's new chief scientific officer pursue?

Pick Your Poison: Overweight or High Cholesterol

Researchers discover that cholesterol-lowering Zocor hindered positive effects of exercise for obese and overweight adults.

The New Generic-Drug Battle Front

One generic pharmaceutical company is determined to chance consumer habits.

Dow Jumps on Virtuous Cycle

Conusmer confidence numbers sent stocks soaring again as the Dow and S&P 500 finished the week at record highs.

Oncothyreon A Speculative Buy

3 Most Important Upcoming FDA Decisions of 2013

The Food and Drug Administration will decide on drugs developed by Merck, Antares Pharmaceuticals, and GlaxoSmithKline in the coming months.
See More Articles...